Regulatory and Compliance Support for Federal Pharmaceutical Sales

The contract provides ongoing regulatory and compliance support for pharmaceutical products sold to the Defense Logistics Agency under federal procurement programs. This includes ensuring adherence to FDA regulations, accurate product labeling, timely adverse event reporting, and compliance with federal pricing requirements, all of which are critical for maintaining eligibility and continuity of pharmaceutical supply to military and veteran healthcare systems. The service scope is designed to support the defense agency’s need for uninterrupted access to compliant medications while mitigating legal and operational risks associated with regulatory noncompliance. This is a subcontract classified under NAICS code 541611 for management consulting services, awarded under the Department of Defense with the contract number SPE2DX25D8022 and delivery order SPE2D926F7496. Although the specific location of performance is not detailed, the work supports federal pharmaceutical sales operations nationwide. The contract was posted on July 21, 2026, and is actively managed to ensure all regulatory obligations are met throughout the lifecycle of pharmaceutical products distributed to DLA's customers across the military and VA networks.